The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...

Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in the U.S., selecting Houston as home to a $6.5 billion plant that will ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a tax ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North Chicago, Illinois. This is a significant milestone in AbbVie’s ongoing ...

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in Virginia. The site, which is located near Charlottesville, will produce APIs for ...

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...